Intrinsic Value of S&P & Nasdaq Contact Us

Coeptis Therapeutics, Inc. COEP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — COEP

Coeptis Therapeutics, Inc. (COEP) has a market capitalization of $45.64M and trades at $12.99. The 52-week range is 6.26-21.41.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-2.81, annual revenue of $1.36M.

The stock has a beta of -0.43, operates in the Healthcare sector.

Trading Data
Current Price$12.99
52-Week Range6.26-21.41
Volume18.95K
Avg Volume (30D)49.85K
Market Cap$45.64M
Beta (1Y)-0.43
Company
IPO Date2020-12-17
Employees5
CEODavid Mehalick
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS19207A2078
CUSIP19207C104
Income (Latest Year)
Revenue$1.36M
Gross Profit$-2.83M
EBITDA$-11.82M
Operating Income$-13.04M
Net Income$-11.92M
EPS$-2.81
EPS Diluted$-2.81
Shares Outstanding$4.23M
Balance Sheet (Latest Year)
Total Assets$19.84M
Current Assets$7.35M
Cash & ST Investments$6.35M
Total Liabilities$2.09M
Total Debt$268.88K
Net Debt$-5.41M
Total Equity$17.75M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-4.6
P/S Ratio33.49
P/B Ratio2.57
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message